Literature DB >> 18703255

A comparative study to screen dementia and APOE genotypes in an ageing East African population.

Chien-Hsiun Chen1, Toshiki Mizuno, Robert Elston, Monica M Kariuki, Kathleen Hall, Fred Unverzagt, Hugh Hendrie, Samuel Gatere, Paul Kioy, Nilesh B Patel, Robert P Friedland, Raj N Kalaria.   

Abstract

Previous studies have established cross-cultural methods to screen for ageing- related dementia and susceptibility genes, in particular Alzheimer's disease (AD) among the Canadian Cree, African Americans and Yoruba in Nigeria. We determined whether the Community Screening Interview for Dementia (CSID), translated into Kikuyu, a major language of Kenya, could be used to evaluate dementia of the Alzheimer type. Using two sets of coefficients of cognitive and informant scores, two discriminant function (DF) scores were calculated for each of 100 elderly (>65 years) Nyeri Kenyans. When the cut-off points were selected for 100% sensitivities, the specificities of the DF scores were remarkably similar (93.75%) in the Kenyan sample. We propose the adapted CSID can be utilised to detect dementia among East Africans. We also show that apolipoprotein E epsilon 4 allele frequencies were high (approximately 30%) and not different between normal subjects and those with probable AD. There was no evidence to suggest years of education or vascular factors were associated with dementia status. (c) 2008 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18703255      PMCID: PMC2857314          DOI: 10.1016/j.neurobiolaging.2008.06.014

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  49 in total

1.  The EURODEM collaborative re-analysis of case-control studies of Alzheimer's disease: implications for public health.

Authors:  C Brayne
Journal:  Int J Epidemiol       Date:  1991       Impact factor: 7.196

2.  Global prevalence of dementia: a Delphi consensus study.

Authors:  Cleusa P Ferri; Martin Prince; Carol Brayne; Henry Brodaty; Laura Fratiglioni; Mary Ganguli; Kathleen Hall; Kazuo Hasegawa; Hugh Hendrie; Yueqin Huang; Anthony Jorm; Colin Mathers; Paulo R Menezes; Elizabeth Rimmer; Marcia Scazufca
Journal:  Lancet       Date:  2005-12-17       Impact factor: 79.321

3.  Improved procedure for eluting DNA from dried blood spots.

Authors:  M Yang; H C Hendrie; K S Hall; O S Oluwole; M E Hodes; A Sahota
Journal:  Clin Chem       Date:  1996-07       Impact factor: 8.327

4.  APOE epsilon4 is not associated with Alzheimer's disease in elderly Nigerians.

Authors:  Oye Gureje; Adesola Ogunniyi; Olusegun Baiyewu; Brandon Price; Frederick W Unverzagt; Rebecca M Evans; Valerie Smith-Gamble; Kathleen A Lane; Sujuan Gao; Kathleen S Hall; Hugh C Hendrie; Jill R Murrell
Journal:  Ann Neurol       Date:  2006-01       Impact factor: 10.422

5.  Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans.

Authors:  H C Hendrie; B O Osuntokun; K S Hall; A O Ogunniyi; S L Hui; F W Unverzagt; O Gureje; C A Rodenberg; O Baiyewu; B S Musick
Journal:  Am J Psychiatry       Date:  1995-10       Impact factor: 18.112

6.  The association between vascular risk factor-mediating medications and cognition and dementia diagnosis in a community-based sample of African-Americans.

Authors:  S S Richards; C L Emsley; J Roberts; M D Murray; K Hall; S Gao; H C Hendrie
Journal:  J Am Geriatr Soc       Date:  2000-09       Impact factor: 5.562

7.  An estimate of the worldwide prevalence and direct costs of dementia in 2003.

Authors:  A Wimo; L Jonsson; B Winblad
Journal:  Dement Geriatr Cogn Disord       Date:  2006-01-09       Impact factor: 2.959

Review 8.  The role of cerebral ischemia in Alzheimer's disease.

Authors:  R N Kalaria
Journal:  Neurobiol Aging       Date:  2000 Mar-Apr       Impact factor: 4.673

9.  Hemoglobin levels and Alzheimer disease: an epidemiologic study in India.

Authors:  Rajesh S Pandav; Vijay Chandra; Hiroko H Dodge; Steven T DeKosky; Mary Ganguli
Journal:  Am J Geriatr Psychiatry       Date:  2004 Sep-Oct       Impact factor: 4.105

10.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

View more
  17 in total

1.  Profiles of Alzheimer's disease-related pathology in an aging urban population sample in India.

Authors:  Dushyant P Purohit; Nirmala O Batheja; Mary Sano; Kusum D Jashnani; Rajesh N Kalaria; Arivarasan Karunamurthy; Shalinder Kaur; Asha S Shenoy; Kathleen Van Dyk; James Schmeidler; Daniel P Perl
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

2.  Clinical implications of APOE genotyping for late-onset Alzheimer's disease (LOAD) risk estimation: a review of the literature.

Authors:  Victoria S Marshe; Ilona Gorbovskaya; Sarah Kanji; Maxine Kish; Daniel J Müller
Journal:  J Neural Transm (Vienna)       Date:  2018-10-31       Impact factor: 3.575

Review 3.  'Evolutionary medicine' perspectives on Alzheimer's Disease: Review and new directions.

Authors:  Molly Fox
Journal:  Ageing Res Rev       Date:  2018-07-27       Impact factor: 10.895

Review 4.  Epidemiology of neurodegenerative diseases in sub-Saharan Africa: a systematic review.

Authors:  Alain Lekoubou; Justin B Echouffo-Tcheugui; Andre P Kengne
Journal:  BMC Public Health       Date:  2014-06-26       Impact factor: 3.295

5.  APOE ε4 and the risk for Alzheimer disease and cognitive decline in African Americans and Yoruba.

Authors:  Hugh C Hendrie; Jill Murrell; Olusegun Baiyewu; Kathleen A Lane; Christianna Purnell; Adesola Ogunniyi; Frederick W Unverzagt; Kathleen Hall; Christopher M Callahan; Andrew J Saykin; Oye Gureje; Ann Hake; Tatiana Foroud; Sujuan Gao
Journal:  Int Psychogeriatr       Date:  2014-02-24       Impact factor: 3.878

6.  High APOE epsilon 4 allele frequencies associated with Alzheimer disease in a Tunisian population.

Authors:  Afef Achouri Rassas; Hela Mrabet Khiari; Sondes Hadj Fredj; Safa Sahnoun; Hend Batti; Nouria Oudiaa Zakraoui; Aroua Cherif; Nadia Anane; Nadia Ben Ali; Taieb Messaoud; Amel Mrabet
Journal:  Neurol Sci       Date:  2011-06-28       Impact factor: 3.307

Review 7.  Exercise, APOE genotype, and the evolution of the human lifespan.

Authors:  David A Raichlen; Gene E Alexander
Journal:  Trends Neurosci       Date:  2014-03-30       Impact factor: 13.837

Review 8.  Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors.

Authors:  Raj N Kalaria; Gladys E Maestre; Raul Arizaga; Robert P Friedland; Doug Galasko; Kathleen Hall; José A Luchsinger; Adesola Ogunniyi; Elaine K Perry; Felix Potocnik; Martin Prince; Robert Stewart; Anders Wimo; Zhen-Xin Zhang; Piero Antuono
Journal:  Lancet Neurol       Date:  2008-07-28       Impact factor: 44.182

Review 9.  Neurogenomics in Africa: Perspectives, progress, possibilities and priorities.

Authors:  Rufus O Akinyemi; Mayowa O Owolabi; Tolulope Oyeniyi; Bruce Ovbiagele; Donna K Arnett; Hemant K Tiwari; Richard Walker; Adesola Ogunniyi; Raj N Kalaria
Journal:  J Neurol Sci       Date:  2016-05-06       Impact factor: 3.181

10.  Dementia prevalence estimates in sub-Saharan Africa: comparison of two diagnostic criteria.

Authors:  Stella-Maria Paddick; Anna R Longdon; Aloyce Kisoli; Catherine Dotchin; William K Gray; Felicity Dewhurst; Paul Chaote; Raj Kalaria; Ahmed M Jusabani; Richard Walker
Journal:  Glob Health Action       Date:  2013-04-03       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.